Search Within

Neeta Pandit-Taskar

  1. "Lloyd Old"
Formats
  1. Journal Article (7)
  2. Meeting Abstract (2)
Groups
  1. Molecular Imaging and Therapy Service (9)
  2. Radiology, Department of (9)
  3. Department of Medicine (8)
  4. GSK Faculty (8)
  5. Solid Tumor Oncology Division (8)
  6. Department of Pathology and Laboratory Medicine (7)

More Groups

People
  1. Lloyd Old (9)
  2. Achim Jungbluth (7)
  3. Steven Larson (6)
  4. Peter Smith-Jones (5)
  5. Chaitanya Divgi (4)
  6. John Humm (4)

More People

Years
  1. 2015 (1)
  2. 2013 (1)
  3. 2011 (2)
  4. 2009 (1)
  5. 2008 (2)
  6. 2007 (2)
Publications
  1. Journal of Clinical Oncology (2)
  2. Journal of Nuclear Medicine (2)
  3. European Journal of Nuclear Medicine and Molecular Imaging (1)
  4. Investigational New Drugs (1)
  5. Journal of Thoracic Oncology (1)
  6. Lancet Oncology (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (2)
  2. Society of Nuclear Medicine (2)
  3. Springer (2)
  4. Elsevier Inc. (1)
  5. Elsevier Science Inc. (1)
  6. Elsevier Science, Inc. (1)

Results (9)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • PET-based compartmental modeling of (124)I-A33 antibody: Quantitative characterization of patient-specific tumor targeting in colorectal cancer
    Journal Article

    Zanzonico, P.; Carrasquillo, J. A.; Pandit-Taskar, N.; O'Donoghue, J. A.; Humm, J. L.; Smith-Jones, P.; Ruan, S.; Divgi, C.; Scott, A. M.; Kemeny, N. E.; more...
    European Journal of Nuclear Medicine and Molecular Imaging (2015)

    Fulltext@MSK | Save
  • Phase I/II study of pegylated arginine deiminase (ADI-PEG 20) in patients with advanced melanoma
    Journal Article

    Ott, P. A.; Carvajal, R. D.; Pandit-Taskar, N.; Jungbluth, A. A.; Hoffman, E. W.; Wu, B. W.; Bomalaski, J. S.; Venhaus, R.; Pan, L.; Old, L. J.; more...
    Investigational New Drugs (2013)

    Fulltext@MSK | Save
  • (124)I-huA33 antibody uptake is driven by A33 antigen concentration in tissues from colorectal cancer patients imaged by immuno-PET
    Journal Article

    O'Donoghue, J. A.; Smith-Jones, P. M.; Humm, J. L.; Ruan, S.; Pryma, D. A.; Jungbluth, A. A.; Divgi, C. R.; Carrasquillo, J. A.; Pandit-Taskar, N.; Fong, Y.; more...
    Journal of Nuclear Medicine (2011)

    Fulltext@MSK | Save
  • (124)I-huA33 antibody PET of colorectal cancer
    Journal Article

    Carrasquillo, J. A.; Pandit-Taskar, N.; O'Donoghue, J. A.; Humm, J. L.; Zanzonico, P.; Smith-Jones, P. M.; Divgi, C. R.; Pryma, D. A.; Ruan, S.; Kemeny, N. E.; more...
    Journal of Nuclear Medicine (2011)

    Fulltext@MSK | Save
  • Phase I/II study of arginine deiminase (ADI-PEG 20) in patients with advanced malignant melanoma (MM)
    Meeting Abstract

    Ott, P. A.; Carvajal, R. D.; Pandit-Taskar, N.; Jungbluth, A. A.; Hoffman, E.; Venhaus, R.; Pan, L.; Old, L.; Pavlick, A. C.; Wolchok, J. D.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • A phase I study of MORAb-003, a humanized monoclonal antibody against folate receptor alpha, in advanced epithelial ovarian cancer
    Meeting Abstract

    Bell-McGuinn, K. M.; Konner, J. A.; Pandit-Taskar, N.; Larson, S. M.; Gerst, S. R.; VanderEls, N.; Old, L.; Weil, S.; Phillips, M.; Aghajanian, C. A.
    Journal of Clinical Oncology (2008)

    Fulltext@MSK | Save
  • Preclinical radioimmunotargeting of folate receptor alpha using the monoclonal antibody conjugate DOTA-MORAb-003
    Journal Article

    Smith-Jones, P. M.; Pandit-Taskar, N.; Cao, W.; O'Donoghue, J.; Philips, M. D.; Carrasquillo, J.; Konner, J. A.; Old, L. J.; Larson, S. M.
    Nuclear Medicine and Biology (2008)

    Fulltext@MSK | Save
  • Targeting Lewis Y (Le(y)) in small cell lung cancer with a humanized monoclonal antibody, hu3S193: A pilot trial testing two dose levels
    Journal Article

    Krug, L. M.; Milton, D. T.; Jungbluth, A. A.; Chen, L. C.; Quaia, E.; Pandit-Taskar, N.; Nagel, A.; Jones, J.; Kris, M. G.; Finn, R.; more...
    Journal of Thoracic Oncology (2007)

    Fulltext@MSK | Save
  • Preoperative characterisation of clear-cell renal carcinoma using iodine-124-labelled antibody chimeric G250 ((124)I-cG250) and PET in patients with renal masses: a phase I trial
    Journal Article

    Divgi, C. R.; Pandit-Taskar, N.; Jungbluth, A. A.; Reuter, V. E.; Gonen, M.; Ruan, S.; Pierre, C.; Nagel, A.; Pryma, D. A.; Humm, J.; more...
    Lancet Oncology (2007)

    Fulltext@MSK | Save